{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:51:31Z","timestamp":1793055091326,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ygyno.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T17:34:59Z","timestamp":1616261699000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan"],"prefix":"10.1016","volume":"161","author":[{"given":"Chih-Long","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Fun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chueh-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Shine","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zen-Shing","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Feng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyng-Wen","family":"Fwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Chang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.02.011_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0010","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","article-title":"The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period","volume":"66","author":"Kjaer","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/jcp.56.8.592","article-title":"Outcome of women with inadequate cervical smears followed up for five years","volume":"56","author":"Hock","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0142(19970625)81:3<139::AID-CNCR2>3.0.CO;2-M","article-title":"Clinicopathologic correlation of the unsatisfactory Papanicolaou smear","volume":"81","author":"Ransdell","year":"1997","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5858\/arpa.2011-0113-OA","article-title":"Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology","volume":"136","author":"Siebers","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0030","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2021.02.011_bb0035","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pvr.2019.04.012","article-title":"False positive cervical HPV screening test results","volume":"7","author":"Schiffman","year":"2019","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task Force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task Force recommendation statement","volume":"320","author":"Force","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0060","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0065","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","article-title":"PAX1 methylation as a potential biomarker for cervical cancer screening","volume":"24","author":"Kan","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0070","first-page":"307","article-title":"Performance of the bladder EpiCheck methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective","volume":"1","author":"Witjes","year":"2018","journal-title":"Blind. Clin. Trial. Eur Urol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13148-020-00902-9","article-title":"Correction to: current status of development of methylation biomarkers for in vitro diagnostic IVD applications","volume":"12","author":"Taryma-Lesniak","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0080","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fgene.2019.01150","article-title":"DNA methylation cancer biomarkers: translation to the clinic","volume":"10","author":"Locke","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0085","article-title":"The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening","volume":"7","author":"Fang","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","article-title":"Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women","volume":"141","author":"De Strooper","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0095","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1186\/s12885-018-5125-8","article-title":"Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages","volume":"18","author":"Schmitz","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/sj.bjc.6605974","article-title":"Cost-effectiveness analysis of human papillomavirus DNA testing and pap smear for cervical cancer screening in a publicly financed health-care system","volume":"103","author":"Chow","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.healthpol.2013.06.008","article-title":"Changes in geographic variation in the uptake of cervical cancer screening in Taiwan: possible effects of \u201cleadership style factor\u201d?","volume":"114","author":"Chiou","year":"2014","journal-title":"Health Policy."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6604262","article-title":"Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening","volume":"98","author":"Huang","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.bjc.6605139","article-title":"Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences","volume":"101","author":"Chen","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0120","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0125","series-title":"Clinical practice guideline for the diagnosis and treatment of gynecologic cancer","author":"National Health Research Institute (NHRI)","year":"2011"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2006.10.004","article-title":"Quality assurance of genotyping array for detection and typing of human papillomavirus","volume":"140","author":"Lin","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0135","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.42.7.3176-3184.2004","article-title":"Detection and typing of human papillomavirus by e6 nested multiplex PCR","volume":"42","author":"Sotlar","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JCM.02453-13","article-title":"Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet international proficiency study","volume":"52","author":"Eklund","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0145","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ijc.25685","article-title":"Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women","volume":"128","author":"Chen","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.02.011_bb0150","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0155","first-page":"187","article-title":"A developmental transcriptomic analysis of Pax1 and Pax9 in embryonic intervertebral disc development","volume":"6","author":"Sivakamasundari","year":"2017","journal-title":"Biol. Open."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.oraloncology.2016.09.007","article-title":"Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer","volume":"62","author":"Cheng","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.oraloncology.2017.11.013","article-title":"Hypermethylated ZNF582 and PAX1 genes in oral scrapings collected from cancer-adjacent normal oral mucosal sites are associated with aggressive progression and poor prognosis of oral cancer","volume":"75","author":"Cheng","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0170","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1038\/s41598-019-45477-5","article-title":"Paired Box-1 (PAX1) activates multiple phosphatases and inhibits kinase cascades in cervical cancer","volume":"9","author":"Su","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2016.08.229","article-title":"Cervical cancer screening in women over 65. CON: Reasons for uncertainty","volume":"142","author":"Sawaya","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2016.08.230","article-title":"Cervical screening in women over 65. PRO: are we asking the right question?","volume":"142","author":"Elit","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1159\/000353769","article-title":"Cytohistologic correlation in premenopausal and postmenopausal women","volume":"57","author":"Gilani","year":"2013","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0190","unstructured":"Cancer Council Australia Cervical Cancer Screening Guidelines Working Party. National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding. Sydney: Cancer Council Australia."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13121195","article-title":"Examining the cervical screening behaviour of women aged 50 or above and its predicting factors: a population-based survey","volume":"13","author":"Chan","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013907","article-title":"Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess","volume":"98","author":"Wen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0971-5851.195751","article-title":"Burden of cervical cancer and role of screening in India","volume":"37","author":"Bobdey","year":"2016","journal-title":"Ind. J. Med. Paediatr. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canep.2018.11.008","article-title":"The burden of cervical cancer in Vietnam: synthesis of the evidence","volume":"59","author":"Thi Nguyen","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2021.02.011_bb0220","article-title":"Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0225","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/ijc.31976","article-title":"Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial","volume":"144","author":"Cook","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0230","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.32614","article-title":"FAM19A4\/miR124-2 methylation in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"147","author":"Vink","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.011_bb0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13148-016-0232-3","article-title":"Combined clinical and genetic testing algorithm for cervical cancer diagnosis","volume":"8","author":"Liou","year":"2016","journal-title":"Clin. Epigenetics"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:47:20Z","timestamp":1715820440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0090825821001487"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}